Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
about
Depression and cardiovascular comorbidityAntidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study.Pharmacotherapy of depression in old age.Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortalityThe risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes.Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.Antidepressant use and risk of adverse outcomes in older people: population based cohort study.The effect of selective serotonin re-uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depression.Antidepressants, antiplatelets and bleeding: one more thing to worry about?Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good.Treatment of anxiety disorders with venlafaxine XR.Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care databaseEffect of selective serotonin reuptake inhibitors on cardiovascular morbidity and mortality.Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).Use of Selective Serotonin Reuptake Inhibitors and Risks of Stroke in Patients with Obsessive Compulsive Disorder: A Population-Based Study.Antidepressant use, depression, and survival in patients with heart failureRisk-benefit analysis of antidepressant drug treatment in the elderly.Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.The Risk of Thromboembolism in Users of Antidepressants and Antipsychotics.The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial.Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants.Prevention of depression in patients with acute coronary syndrome (DECARD) randomized trial: effects on and by self-reported health.
P2860
Q28210833-554CDD38-3CB4-4C3A-BDCA-03B193A16F75Q30838926-DB484F72-0D3C-4BEC-971D-9A31EB68DFFFQ33223169-0F689A98-6529-49C1-95E5-47E7BA4B005FQ33568470-168924EF-2430-44F2-A7D8-512D644BD390Q34083409-953417E9-565D-4BBB-8622-3172B0314064Q34158301-AD40CD52-5DC8-40B4-A6CB-C99556BEE80EQ34182611-E6295465-D989-4223-B361-50507A64DDFAQ34571252-C8138359-9A13-4C8A-8FEB-B750D458DFD9Q35144173-2445D7A6-5820-49B6-AD88-286374749965Q35219689-15C37919-B1EA-4E85-9944-9F160BEF1AAAQ35551111-CAD3E966-235C-4112-BDE4-0365D6D3CA4BQ35907475-64AFC577-E0D7-46C0-8FC2-4F2862C9B425Q36419538-926CFC75-3122-4AF5-A353-DE365546AA8AQ36719034-9C3A2C3B-B6AF-4433-9081-A37BD0574FF8Q37089567-69E60A31-875E-4AC0-89B5-01571B56ACD7Q37171411-E1CD01E6-77F1-4592-9CA4-3F362588782EQ37245217-0B3F64E8-1C39-4134-862A-ECFADA34806EQ37467525-EFFCEF93-7711-4EE6-B59F-5100FD783DDDQ38286201-6EC62946-2F02-4F41-8D7F-0CBC9011C97CQ38526162-58A185C2-C696-4F2A-9BE5-B45F8298FA79Q39077689-7C1C5F13-A01B-45E4-A012-80717B4803DFQ40577573-558B0AD4-596A-4A52-B615-5D0ED7085F85Q41856640-B0528D79-125C-4CB9-8CA5-295512C08CBCQ42905444-4A392CB8-CB38-4294-A95F-23054F43FB2EQ44906190-78ADF673-6C1C-4CE4-A0E4-1F71488459AFQ48329741-858DC0BA-310B-4F81-ACEA-B1E6C48052AF
P2860
Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Current use of selective serot ...... f acute myocardial infarction.
@en
type
label
Current use of selective serot ...... f acute myocardial infarction.
@en
prefLabel
Current use of selective serot ...... f acute myocardial infarction.
@en
P2093
P1433
P1476
Current use of selective serot ...... f acute myocardial infarction.
@en
P2093
Christoph R Meier
Lorenz M Fischer
Raymond G Schlienger
P304
P356
10.2165/00002018-200427140-00006
P50
P577
2004-01-01T00:00:00Z
P6179
1042221865